Enter your terms above and click the 'Search' button.

Showing articles 0 to 10 of 10 Filter Applied: immune checkpoint inhibitors (Click to remove) Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021 Progressive Hemiparesis and White Matter Abnormalities in an HIV-Negative Patient Neurol 100:1156-1163, Jabbari,E.,et al, 2023 A 69-Year-Old Woman with Ophthalmoplegia Neurol 104:e213763, Yu, H & Frey, J, 2025 A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations Neurol 99:166-171, Kizza, J.,et al, 2022 Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors Neurol 96:e866-e875, Vogrig, A.,et al, 2021 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy NEJM 380:1597-1605, Cortese, I.,et al, 2019 Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Showing articles 0 to 10 of 10